Brief: Medistim Q4 Sales NOK 135.6 Mln

Medistim ASA

29/02/2024 07:35

Feb 29 (Reuters) - Medistim ASA  MEDI.OL :
    * SALES ENDED AT MNOK 135.6, 4.4 % BELOW OUR ALL-TIME HIGH
Q4 LAST
YEAR (MNOK 141.8)
    * OPERATING PROFIT (EBIT) FOR Q4 ENDED AT MNOK 22.3 GIVING A
16.4
% EBIT MARGIN (MNOK 36.5, A 25.7 % MARGIN).
    * IN 2023, OUR LARGEST MARKET, USA, EXPERIENCED A DECREASE
IN
CAPITAL SALES, BUT RISING PROBE SALES INDICATE A GROWING
UTILIZATION.
    * PROPOSES TO GENERAL ASSEMBLY A DIVIDEND OF NOK 4.50 (NOK
4.50)
PER SHARE

Source text for Eikon:  ID:nObiPWKXCa 
Further company coverage:  MEDI.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))